Parametrica Management’s Immunogen Inc IMGN Stock Holding History

Parametrica Management’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-15,477	Closed	-$164K	–	83
2014 Q3	$164K	Buy	+15,477	New	+$175K	0.95%	53

Other funds holding IMGN

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Parametrica Management's IMGN Position: Q4 2014 in Review

Parametrica Management sold out of Immunogen Inc (IMGN) in Q4 2014, closing a stake of 15,477 shares — an estimated $164K sold.

Parametrica Management first reported a position in IMGN in Q3 2014 and held it in 1 quarter. The position peaked at $164K in Q3 2014. 131 funds tracked by Wall St. Rank hold IMGN as of Q4 2014.

Parametrica Management reported no remaining Immunogen Inc position as of Q4 2014 after selling out during the quarter.
Parametrica Management sold 15,477 Immunogen Inc shares in Q4 2014, an estimated $164K.
Parametrica Management first reported a position in Immunogen Inc in Q3 2014 and held it in 1 quarter.
Parametrica Management's Immunogen Inc position peaked at $164K in Q3 2014.
131 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2014.

Based on Parametrica Management's 13F filing for Q4 2014, filed 9 Jan 2015.